Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

NewLink Genetics (NLNK) Upgraded From Sell to Hold

By Amanda Schiavo
Jun 23, 2015 10:34 AM EDT

Time Inc. to Partner With Barclays to Launch Fortune 500 Equal Weighted Index

By Roberto Pedone
Jun 16, 2015 1:49 PM EDT

Just What Jittery U.S. Markets Don't Need -- More Global Growth Worries

By Roberto Pedone
Apr 21, 2015 1:41 PM EDT

Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)

By Marissa Goodbody
Mar 12, 2015 10:01 AM EDT

Why Portola Pharmaceuticals (PTLA) Stock is Plunging Today

By Roberto Pedone
Mar 12, 2015 9:31 AM EDT

Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Higher

By TheStreet Wire
Oct 22, 2014 4:32 PM EDT

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab

By Adam Feuerstein
Sep 16, 2014 1:04 PM EDT

EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel

By Adam Feuerstein
Jun 12, 2014 8:00 AM EDT

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab

By Adam Feuerstein
Nov 22, 2013 6:00 AM EST

4 Stocks Under $10 Making Big Moves

By Roberto Pedone
Apr 25, 2013 1:44 PM EDT

4 Under-$10 Biotech Stocks in Breakout Territory

By Roberto Pedone
Jan 8, 2013 2:13 PM EST

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

By Adam Feuerstein
Nov 9, 2012 6:30 AM EST

Grom Social Offers a Safe Alternative to Facebook for Young People

By Seeking Alpha
Aug 8, 2012 5:19 PM EDT

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report

By Adam Feuerstein
Aug 3, 2012 6:00 AM EDT

Inflating Market Bubble Not Quite Ready to Pop

By Roberto Pedone
Jul 10, 2012 2:06 PM EDT

Stocks Begin 2014 With Inflating Bubbles

By Roberto Pedone
Jun 1, 2012 1:41 PM EDT

Grom Social Offers a Safe Alternative to Facebook for Young People

PERSONAL FINANCE

By Robert Holmes
Sep 28, 2011 1:58 PM EDT

5 Hated Earnings Stocks You Should Love

By Stockpickr Staff
Sep 27, 2011 2:01 PM EDT

Uncertainty Remaining in Boston Scientific

By Adam Feuerstein
Sep 26, 2011 10:54 AM EDT

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest

By Adam Feuerstein
Sep 16, 2011 5:48 AM EDT

CTI Biopharma Posts Positive Myelofibrosis Study Results

By Adam Feuerstein
Sep 12, 2011 11:41 AM EDT

FDA Tells Delcath No Approval Without New Clinical Trial

By Adam Feuerstein
Sep 9, 2011 6:08 AM EDT

FDA Tells Delcath No Approval Without New Clinical Trial

By Adam Feuerstein
May 9, 2011 10:36 AM EDT

Galapagos Receives a Rousing Welcome on Its First Day of Trading

By Adam Feuerstein
Mar 4, 2011 7:10 AM EST

Grom Social Offers a Safe Alternative to Facebook for Young People

By Shanthi Bharatwaj
Mar 2, 2011 1:04 PM EST